Are the directors selling as well in the last few days? Otherwise they will be stuck at $2.2 issued share price for a while. The share price is retreating back to a dollar.
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game